PASQUALE, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 1.472
EU - Europa 1.388
AS - Asia 166
AF - Africa 5
SA - Sud America 3
Totale 3.034
Nazione #
US - Stati Uniti d'America 1.470
IE - Irlanda 489
UA - Ucraina 246
GB - Regno Unito 205
DE - Germania 136
IT - Italia 117
CN - Cina 67
FI - Finlandia 63
SG - Singapore 62
SE - Svezia 54
TR - Turchia 35
GR - Grecia 31
BE - Belgio 15
FR - Francia 11
CZ - Repubblica Ceca 10
AT - Austria 3
BR - Brasile 3
NL - Olanda 3
RO - Romania 3
CA - Canada 2
EG - Egitto 2
BW - Botswana 1
GH - Ghana 1
IR - Iran 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
VN - Vietnam 1
Totale 3.034
Città #
Dublin 489
Jacksonville 369
Chandler 315
Ann Arbor 79
Princeton 72
Medford 62
Boardman 55
San Mateo 45
Caserta 40
Singapore 36
Bremen 32
Wilmington 32
Woodbridge 30
Roxbury 25
Marano 24
Cambridge 16
Brussels 15
New York 14
Nanjing 13
Des Moines 12
Beijing 10
Brno 9
Altamura 8
Auburn Hills 8
Jinan 7
Houston 6
Ashburn 5
Mountain View 5
Munich 5
Shenyang 5
Dearborn 4
Hangzhou 4
Nanchang 4
Changsha 3
Düsseldorf 3
Erice 3
Hefei 3
Helsinki 3
London 3
Los Angeles 3
Naples 3
Afragola 2
Amsterdam 2
Ferrara 2
Guangzhou 2
Napoli 2
Norwalk 2
Potenza 2
Tanta 2
Tianjin 2
Torre Del Greco 2
Vienna 2
Zhengzhou 2
Ashton-under-lyne 1
Atlanta 1
Bologna 1
Cava De' Tirreni 1
Escondido 1
Fairfield 1
Gaborone 1
Hanoi 1
Hebei 1
Jiaxing 1
Lanzhou 1
Leawood 1
Leeds 1
Lowestoft 1
Luxembourg 1
Marigliano 1
Marseille 1
Ottawa 1
Paris 1
Pozzuoli 1
Prague 1
Qualiano 1
Rabat 1
Rotterdam 1
Secaucus 1
Shanghai 1
São Paulo 1
Taiyuan 1
Taizhou 1
Toronto 1
Zanjan 1
Totale 1.934
Nome #
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 107
Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven hepatitis C: a multicenter study 105
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 81
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 76
An attempt to improve classification of HCV-correlated chronic hepatitis 74
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 70
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 65
Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies 63
Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis 62
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 55
Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study 54
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients 53
Anti-HBc positività was associated with histological cirrhosis in patients with chronic hepatitis C 52
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 52
Delta agent infection: an unfavourable event in HBsAg positive chronic hepatitis 50
Together … to take care: multidisciplinary management of hepatitis C virus treatment in randomly selected drug users with chronic hepatitis 49
Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment 49
Distribution pattern of hepatitis C Virus genotypes and correlation with viral load and risk factors in chronic positive patients 48
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 48
[Spontaneous bacterial peritonitis in patients with liver cirrhosis. Differential aspects with portal thrombosis] 48
Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients 47
Bacterial granulomatous hepatitis. 47
Liver Histology in Patients With HBsAg Negative Anti-HBc and Anti-HCV Positive Chronic Hepatitis 47
Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study 46
Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients 44
Clinical and histological aspects of chronic HCV infection and cirrhosis 44
Does an "autoimmune"profile affect the clinical profile of chronic hepatitis C? An italian multicentre survey 44
Azathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosis 44
Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis 44
Liver histology in 34 "HPsAg long-term healthy carriers 43
Infestazioni da Metazoi 43
Hepatic cryptococcosis in a heart transplant recipient 42
[Elevata prevalenza ma bassa incidenza della infezione da HGV in pazienti con epatite cronica C] 42
Liver Histology in HIV/HCV Coinfected and HCV-monoinfected Patients with Persistently Normal Alanine Aminotransferases (PNAL) 41
Differential diagnosis between benign and malignant biliary tract obstruction: discriminative usefulness of some clinical and laboratory data 41
Clinical Presentation, Outcomes, and Response to Therapy Among Patients with Acute Exacerbation of Chronic Hepatitis C. 41
Prospective validation of the CLIP score:A new prognostic system for patients with ciurrhosis and hepatocellular carcinoma 40
Influence of chronic coinfection with hepatitis B and C virus on liver histology 40
Interaction between HDV and HBV infection in HBsAg-chronic carriers 38
Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trial 38
Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection. 38
Non responders to interferon therapy among chronic hepatitis patients infected with hepatitis C virus 38
The epidemiology of hepatitis delta infection in Italy over the last 18 years 37
Is liver biopsy necessary for hepatitis C virus carriers with persistently normal aminotransferase levels? 37
Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe 37
The significance of the Australia antigen (HBsAg) persistent healthy carrier "status": a long-term follow-up study of 34 cases 37
Icteric hepatitis in a patient with non-Hodgkin's lymphoma treated by rituximab-based chemotherapy] 37
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 37
Interferon monotherapy may still be a therapeutic option for selected patients with chronic hepatitis C. A prospective study in patients with earl viral clearance 36
Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients 35
Epatite C: immunità e patologia 35
Prospective Validation of the CLIP Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators 35
Age and Gender Distribution of Hepatitis C Virus Genotypes in the Metropolitan Area of Naples 35
The growth-hormone in long-term steroid-treated patients with chronic active hepatitis 34
Uselessness of liver biopsy in patients with chronic hepatitis C virus infection and persistently normal aminotransferase levels 32
Tamoxifen in the tretment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled tral 31
Hyperendemicity of viral hepatitis in the Neapolitan area: an epidemiological study 30
Malattie endemiche nelle aree tropicali 30
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 28
The CB2-63 RR variant is an independent predictor of severe liver necroinflammation in chronic hepatitis B 28
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 28
Hepatic Steatosis And necro-Inflammatory Activity overestimate Liver Stiffness by Transient Elastography in Staging Liver Fibrosis in Chronic Hepatitis C 27
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 27
Elevata prevalenza ma bassa incidenza della infezione da HGV in paziente con epatite cronica C 26
null 26
HCV reinfection after liver transplantation for HCV cirrhosis 24
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 23
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings 22
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 21
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 21
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, january 2012 to june 2013 16
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases 13
Clinical management of imported malaria in Italy: Results from a national cross-sectional survey in 2015 12
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 12
Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma 11
Totale 3.113
Categoria #
all - tutte 12.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020369 65 62 8 0 62 13 79 15 42 4 10 9
2020/2021512 57 0 67 15 80 5 68 60 13 94 41 12
2021/2022407 49 0 2 7 137 2 15 12 12 27 36 108
2022/20231.052 78 10 22 95 131 89 0 79 488 9 29 22
2023/2024321 34 9 20 34 119 17 1 3 0 7 31 46
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 3.113